Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Chinese Children, Adults and the Elderly: A Phase 4, Randomized, Double-Blind, Active-Controlled Clinical Trial

ABSTRACT:

SUBMITTER: Liu X 

PROVIDER: S-EPMC12389771 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature